Brought to you by 
J&J to acquire 3-D Pharmaceuticals
28 Apr 2005
Executive Summary
Aiming to boost its in-house R&D capabilities, Johnson & Johnson has agreed to buy 3-Dimensional Pharmaceuticals (platform for discovering small-molecule drugs) for about $129.7mm in cash. The companies have been partners in discovery and development projects since 2001.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J to acquire 3-D Pharmaceuticals
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice